Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
On Demand
Back
Favorite
Facebook
Tweet
Print
James H. Stark, PhD
Medical Study Lead, Senior Director
Pfizer Biopharma Group
Poster(s):
(P-599) 6-Valent, OspA-Based VLA15 Lyme Disease Vaccine Candidate Against Lyme Borreliosis in a Healthy Pediatric and Adult Study Population: A Phase 2 Study Update
Thursday, October 17, 2024
12:15 PM – 1:30 PM
US PT
(P-1287) Incidence of Symptomatic Lyme Borreliosis in Nine European Countries, 2018−2022
Friday, October 18, 2024
12:15 PM – 1:30 PM
US PT
(P-1291) Racial disparities in Lyme disease among beneficiaries of US Medicaid and Medicare
Friday, October 18, 2024
12:15 PM – 1:30 PM
US PT